leadit 2.1.2 (BioSolveIT GmbH)
Structured Review

Leadit 2.1.2, supplied by BioSolveIT GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leadit+2%2E1%2E2/leadit+version+2+3+2/pmc07697925-5-102-104
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Antifungal Drug Repurposing"
Article Title: Antifungal Drug Repurposing
Journal: Antibiotics
doi: 10.3390/antibiotics9110812
Figure Legend Snippet: Tools and procedures applicable to the in silico/computational antifungal drug repurposing.
Techniques Used: Biomarker Discovery, Selection, Software, Modification, Bioassay, MTT Microdilution Assay
Related Articles
Software:Article Title: Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents Article Snippet: Molecular Operating Environment (MOE) 2013.08 package license was purchased from Chemical Computing Group Inc (Montreal, QC, Canada), and Article Title: Stepwise design, synthesis, and in vitro antifungal screening of ( Z )-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity Article Snippet: Molecular Operating Environment (MOE) 2014.09 package license was purchased from Chemical Computing Group Inc, Montreal, QC, Canada and Article Title: Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole Article Snippet: This study describes synthesis of a new group of triaryl-1,2,4-oxadiazole derivatives and their anticancer activities.. The target compounds were prepared from reaction of different imines and 4-substituted benzohydroxyiminoyl chlorides.. All the synthesized compounds were screened for antiproliferative activities against MCF7 and K562 cell lines using MTT assay at 50-lM concentration. Article Title: Antifungal Drug Repurposing Article Snippet: Ligand preparation and Molecular docking , OMEGA v.3.0.0.1 software by OpenEye Scientific [ ]; QUACPAC v.1.7.0.2 software by OpenEye Scientific [ ]; OEDocking suite v.3.2.0 by OpenEye Scientific [ ]; FRED program with the ChemGauss4 score function in the OEDocking suite , Protein Preparation Wizard of Schrodinger’s suite 8.5 (Chimeric 1EA1); Docking between internal ligand (fluconazole) and 1EA1 in Schrodinger’s suite 8.5; GROMACS 5.0 for molecular dynamics simulations with GROMOS9643a1 force field; LIGPREP and Selection:Article Title: Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents Article Snippet: Molecular Operating Environment (MOE) 2013.08 package license was purchased from Chemical Computing Group Inc (Montreal, QC, Canada), and Article Title: Stepwise design, synthesis, and in vitro antifungal screening of ( Z )-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity Article Snippet: Molecular Operating Environment (MOE) 2014.09 package license was purchased from Chemical Computing Group Inc, Montreal, QC, Canada and Article Title: Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole Article Snippet: This study describes synthesis of a new group of triaryl-1,2,4-oxadiazole derivatives and their anticancer activities.. The target compounds were prepared from reaction of different imines and 4-substituted benzohydroxyiminoyl chlorides.. All the synthesized compounds were screened for antiproliferative activities against MCF7 and K562 cell lines using MTT assay at 50-lM concentration. Article Title: Antifungal Drug Repurposing Article Snippet: Ligand preparation and Molecular docking , OMEGA v.3.0.0.1 software by OpenEye Scientific [ ]; QUACPAC v.1.7.0.2 software by OpenEye Scientific [ ]; OEDocking suite v.3.2.0 by OpenEye Scientific [ ]; FRED program with the ChemGauss4 score function in the OEDocking suite , Protein Preparation Wizard of Schrodinger’s suite 8.5 (Chimeric 1EA1); Docking between internal ligand (fluconazole) and 1EA1 in Schrodinger’s suite 8.5; GROMACS 5.0 for molecular dynamics simulations with GROMOS9643a1 force field; LIGPREP and Biomarker Discovery:Article Title: Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents Article Snippet: Molecular Operating Environment (MOE) 2013.08 package license was purchased from Chemical Computing Group Inc (Montreal, QC, Canada), and Article Title: Stepwise design, synthesis, and in vitro antifungal screening of ( Z )-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity Article Snippet: Molecular Operating Environment (MOE) 2014.09 package license was purchased from Chemical Computing Group Inc, Montreal, QC, Canada and Article Title: Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole Article Snippet: This study describes synthesis of a new group of triaryl-1,2,4-oxadiazole derivatives and their anticancer activities.. The target compounds were prepared from reaction of different imines and 4-substituted benzohydroxyiminoyl chlorides.. All the synthesized compounds were screened for antiproliferative activities against MCF7 and K562 cell lines using MTT assay at 50-lM concentration. Article Title: Antifungal Drug Repurposing Article Snippet: Ligand preparation and Molecular docking , OMEGA v.3.0.0.1 software by OpenEye Scientific [ ]; QUACPAC v.1.7.0.2 software by OpenEye Scientific [ ]; OEDocking suite v.3.2.0 by OpenEye Scientific [ ]; FRED program with the ChemGauss4 score function in the OEDocking suite , Protein Preparation Wizard of Schrodinger’s suite 8.5 (Chimeric 1EA1); Docking between internal ligand (fluconazole) and 1EA1 in Schrodinger’s suite 8.5; GROMACS 5.0 for molecular dynamics simulations with GROMOS9643a1 force field; LIGPREP and Modification:Article Title: Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents Article Snippet: Molecular Operating Environment (MOE) 2013.08 package license was purchased from Chemical Computing Group Inc (Montreal, QC, Canada), and Article Title: Stepwise design, synthesis, and in vitro antifungal screening of ( Z )-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity Article Snippet: Molecular Operating Environment (MOE) 2014.09 package license was purchased from Chemical Computing Group Inc, Montreal, QC, Canada and Article Title: Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole Article Snippet: This study describes synthesis of a new group of triaryl-1,2,4-oxadiazole derivatives and their anticancer activities.. The target compounds were prepared from reaction of different imines and 4-substituted benzohydroxyiminoyl chlorides.. All the synthesized compounds were screened for antiproliferative activities against MCF7 and K562 cell lines using MTT assay at 50-lM concentration. Article Title: Antifungal Drug Repurposing Article Snippet: Ligand preparation and Molecular docking , OMEGA v.3.0.0.1 software by OpenEye Scientific [ ]; QUACPAC v.1.7.0.2 software by OpenEye Scientific [ ]; OEDocking suite v.3.2.0 by OpenEye Scientific [ ]; FRED program with the ChemGauss4 score function in the OEDocking suite , Protein Preparation Wizard of Schrodinger’s suite 8.5 (Chimeric 1EA1); Docking between internal ligand (fluconazole) and 1EA1 in Schrodinger’s suite 8.5; GROMACS 5.0 for molecular dynamics simulations with GROMOS9643a1 force field; LIGPREP and Bioassay:Article Title: Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents Article Snippet: Molecular Operating Environment (MOE) 2013.08 package license was purchased from Chemical Computing Group Inc (Montreal, QC, Canada), and Article Title: Stepwise design, synthesis, and in vitro antifungal screening of ( Z )-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity Article Snippet: Molecular Operating Environment (MOE) 2014.09 package license was purchased from Chemical Computing Group Inc, Montreal, QC, Canada and Article Title: Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole Article Snippet: This study describes synthesis of a new group of triaryl-1,2,4-oxadiazole derivatives and their anticancer activities.. The target compounds were prepared from reaction of different imines and 4-substituted benzohydroxyiminoyl chlorides.. All the synthesized compounds were screened for antiproliferative activities against MCF7 and K562 cell lines using MTT assay at 50-lM concentration. Article Title: Antifungal Drug Repurposing Article Snippet: Ligand preparation and Molecular docking , OMEGA v.3.0.0.1 software by OpenEye Scientific [ ]; QUACPAC v.1.7.0.2 software by OpenEye Scientific [ ]; OEDocking suite v.3.2.0 by OpenEye Scientific [ ]; FRED program with the ChemGauss4 score function in the OEDocking suite , Protein Preparation Wizard of Schrodinger’s suite 8.5 (Chimeric 1EA1); Docking between internal ligand (fluconazole) and 1EA1 in Schrodinger’s suite 8.5; GROMACS 5.0 for molecular dynamics simulations with GROMOS9643a1 force field; LIGPREP and MTT Microdilution Assay:Article Title: Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents Article Snippet: Molecular Operating Environment (MOE) 2013.08 package license was purchased from Chemical Computing Group Inc (Montreal, QC, Canada), and Article Title: Stepwise design, synthesis, and in vitro antifungal screening of ( Z )-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity Article Snippet: Molecular Operating Environment (MOE) 2014.09 package license was purchased from Chemical Computing Group Inc, Montreal, QC, Canada and Article Title: Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole Article Snippet: This study describes synthesis of a new group of triaryl-1,2,4-oxadiazole derivatives and their anticancer activities.. The target compounds were prepared from reaction of different imines and 4-substituted benzohydroxyiminoyl chlorides.. All the synthesized compounds were screened for antiproliferative activities against MCF7 and K562 cell lines using MTT assay at 50-lM concentration. Article Title: Antifungal Drug Repurposing Article Snippet: Ligand preparation and Molecular docking , OMEGA v.3.0.0.1 software by OpenEye Scientific [ ]; QUACPAC v.1.7.0.2 software by OpenEye Scientific [ ]; OEDocking suite v.3.2.0 by OpenEye Scientific [ ]; FRED program with the ChemGauss4 score function in the OEDocking suite , Protein Preparation Wizard of Schrodinger’s suite 8.5 (Chimeric 1EA1); Docking between internal ligand (fluconazole) and 1EA1 in Schrodinger’s suite 8.5; GROMACS 5.0 for molecular dynamics simulations with GROMOS9643a1 force field; LIGPREP and Binding Assay:Article Title: Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents Article Snippet: Molecular Operating Environment (MOE) 2013.08 package license was purchased from Chemical Computing Group Inc (Montreal, QC, Canada), and Article Title: Stepwise design, synthesis, and in vitro antifungal screening of ( Z )-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity Article Snippet: Molecular Operating Environment (MOE) 2014.09 package license was purchased from Chemical Computing Group Inc, Montreal, QC, Canada and Article Title: Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole Article Snippet: This study describes synthesis of a new group of triaryl-1,2,4-oxadiazole derivatives and their anticancer activities.. The target compounds were prepared from reaction of different imines and 4-substituted benzohydroxyiminoyl chlorides.. All the synthesized compounds were screened for antiproliferative activities against MCF7 and K562 cell lines using MTT assay at 50-lM concentration. Article Title: Antifungal Drug Repurposing Article Snippet: Ligand preparation and Molecular docking , OMEGA v.3.0.0.1 software by OpenEye Scientific [ ]; QUACPAC v.1.7.0.2 software by OpenEye Scientific [ ]; OEDocking suite v.3.2.0 by OpenEye Scientific [ ]; FRED program with the ChemGauss4 score function in the OEDocking suite , Protein Preparation Wizard of Schrodinger’s suite 8.5 (Chimeric 1EA1); Docking between internal ligand (fluconazole) and 1EA1 in Schrodinger’s suite 8.5; GROMACS 5.0 for molecular dynamics simulations with GROMOS9643a1 force field; LIGPREP and |